On August 20, 2026, a new publication on teduglutide appeared in Pediatric Surgery International. The paper, titled "Efficacy and safety of teduglutide in children with short bowel syndrome: a narrative review," is a narrative review focused on pediatric patients with short bowel syndrome.
The publication is listed under the journal Pediatric Surgery International and is identified by PubMed ID 42622692. As a narrative review, the article compiles existing information on the topic rather than presenting new original trial data.
No specific findings, outcomes, or safety signals from the review have been detailed here beyond its title and publication venue. Readers interested in the full scope of the review's discussion on efficacy and safety should consult the original article directly.
Teduglutide remains an approved compound, and this publication adds to the body of literature examining its use in pediatric short bowel syndrome. For further background on teduglutide, readers can refer to the compound overview.